Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H‐N‐propylnorapomorphine sites
- 1 May 1983
- journal article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 118 (1), 79-81
- https://doi.org/10.1111/j.1748-1716.1983.tb07244.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the ratNeuroscience Letters, 1983
- Modulation by cholecystokinins of 3H‐spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sitesActa Physiologica Scandinavica, 1981
- Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptorsEuropean Journal of Pharmacology, 1981
- Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptidesJournal of Neural Transmission, 1981
- Optimal Conditions for [3H]Apomorphine Binding and Anomalous Equilibrium Binding of [3H]Apomorphine and [3H]Spiperone to Rat Striatal Membranes: Involvement of Surface Phenomena Versus Multiple Binding SitesJournal of Neurochemistry, 1981
- A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracingNeuroscience, 1980
- Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injectionEuropean Journal of Pharmacology, 1980